7 May, 2014 by The TZ Newswire Staff Comments Off on How Bank Of America Explains The Treasury Bid: "Cold Weather"
How Bank Of America Explains The Treasury Bid: "Cold Weather"
Bank of America, whose stubborn, and quite abysmal “short Treasurys” call, has been one of the worst sellside trade recos in recent history and cost investors countless losses, has an update. Only instead of doing a mea culpa and finally admitting it was wrong, the bailed out bank has decided to provide humor instead. Namely it too has joined the ranks of countless others providing an “explanation” (or in its case, an “excuse”) for the relentless bond bid. The punchline: “cold weather.“
7 May, 2014 by The TZ Newswire Staff Comments Off on Meet Alibaba’s brash outsider, Jack Ma
Meet Alibaba’s brash outsider, Jack Ma
Jack Ma began his career as an English teacher. Today, two of his websites account for more than half of the packages shipped through China.
7 May, 2014 by The TZ Newswire Staff Comments Off on Traffic, ad growth on big winning streak: AOL chief
Traffic, ad growth on big winning streak: AOL chief
AOL saw its seventh quarter in a row of consumer traffic growth and the eleventh straight quarter of advertising growth, company Chairman and CEO Tim Armstrong tells CNBC.
7 May, 2014 by The TZ Newswire Staff Comments Off on Washington delays big banks from writing wills before a collapse
Washington delays big banks from writing wills before a collapse
The banks have already had to submit two versions of the documents, neither of which were up to the standards of the FDIC and the Federal Reserve. Some regulators say plans submitted so far wouldn’t provide much of a roadmap if a new crisis were to threaten a large bank today.
7 May, 2014 by The TZ Newswire Staff Comments Off on AstraZeneca takeover would benefit science: Pfizer
AstraZeneca takeover would benefit science: Pfizer
Pfizer (PFE) sought to allay fears that its proposed $106 billion takeover of AstraZeneca (AZN.L) would deal a blow to drug research, saying the new company would bolster innovative science and speed the development of new treatments. AstraZeneca, Britain’s second-largest drugs company, has rejected successive approaches from its larger American rival. As political opposition to the plan grew, Pfizer reiterated its commitment to the deal, posting a graphic on its website that touted the benefits of a merger.
7 May, 2014 by The TZ Newswire Staff Comments Off on Allianz CEO defends Pimco against shareholder criticism
Allianz CEO defends Pimco against shareholder criticism
Allianz’s Michael Diekmann says there’s no reason for shareholders to complain about Pimco.
read more
7 May, 2014 by The TZ Newswire Staff Comments Off on Outside the Box: What the Fed’s Yellen should say on the Hill today
Outside the Box: What the Fed’s Yellen should say on the Hill today
‘Interest rates can remain low to support higher wages,’ she ought to say, writes Tim Mullaney.
read more